Literature DB >> 18823303

QT prolongation and torsade de pointes associated with solifenacin in an 81-year-old woman.

Hiroshi Asajima, Yohei Sekiguchi, Shoji Matsushima, Naotaka Saito, Takahiko Saito.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18823303      PMCID: PMC2675767          DOI: 10.1111/j.1365-2125.2008.03298.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

Review 1.  Drug-induced prolongation of the QT interval.

Authors:  Dan M Roden
Journal:  N Engl J Med       Date:  2004-03-04       Impact factor: 91.245

2.  Torsades de pointes complicating treatment with terodiline.

Authors:  A A McLeod; S Thorogood; S Barnett
Journal:  BMJ       Date:  1991-06-15

Review 3.  Solifenacin in overactive bladder syndrome.

Authors:  Christopher K Payne
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  Torsades de pointes ventricular tachycardia and terodiline.

Authors:  M J Connolly; P S Astridge; E G White; C A Morley; J C Cowan
Journal:  Lancet       Date:  1991-08-10       Impact factor: 79.321

Review 5.  Clinical pharmacokinetics of amlodipine.

Authors:  P A Meredith; H L Elliott
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

Review 6.  Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes.

Authors:  Akshay Gupta; Andrew T Lawrence; Kousik Krishnan; Clifford J Kavinsky; Richard G Trohman
Journal:  Am Heart J       Date:  2007-06       Impact factor: 4.749

Review 7.  The Q-T interval and antimuscarinic drugs.

Authors:  Roger Dmochowski; David R Staskin
Journal:  Curr Urol Rep       Date:  2005-11       Impact factor: 2.862

  7 in total
  4 in total

Review 1.  Reckless administration of QT interval-prolonging agents in elderly patients with drug-induced torsade de pointes.

Authors:  Galia Jackobson; Narin Nard Carmel; Dor Lotan; Anjelika Kremer; Dan Justo
Journal:  Z Gerontol Geriatr       Date:  2016-11-22       Impact factor: 1.281

2.  Management of urinary incontinence.

Authors:  George A Demaagd; Timothy C Davenport
Journal:  P T       Date:  2012-06

3.  Solifenacin linked QT interval prolongation and torsades de pointes.

Authors:  Jonathan J H Bray; Jules C Hancox
Journal:  Ther Adv Drug Saf       Date:  2017-04-10

Review 4.  Cardiac effects of muscarinic receptor antagonists used for voiding dysfunction.

Authors:  Karl-Erik Andersson; Lysanne Campeau; Brian Olshansky
Journal:  Br J Clin Pharmacol       Date:  2011-08       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.